How do you diagnose Pyrexia (Fever) of Unknown Origin (PUO) using history, examination, and lab investigations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Pyrexia of Unknown Origin (PUO): A Systematic Approach

The diagnosis of Pyrexia of Unknown Origin requires a methodical, step-by-step approach focusing on detailed history, targeted physical examination, and strategic laboratory and imaging investigations to identify the underlying cause, which is most commonly infectious, inflammatory, or neoplastic in nature. 1

Definition and Classification

PUO is defined as:

  • Fever higher than 38.3°C (100.9°F)
  • Persisting for at least 3 weeks
  • No diagnosis despite 3 outpatient visits or in-patient days 1

PUO can be classified into four distinct subcategories:

  • Classical PUO
  • Nosocomial PUO
  • Neutropenic PUO
  • HIV-related PUO 1

History-Taking Clues

Travel History

  • Detailed geographical history: Document exact dates and places of travel 2
  • Time of onset and duration of symptoms: Most tropical infections become symptomatic within 21 days of exposure 2
  • Risk activities undertaken: Document specific exposures (e.g., swimming in freshwater, animal contact) 2
  • Higher suspicion for endemic infections based on travel location:
    • Western countries: Endocarditis, Q fever, intra-abdominal abscesses
    • India/tropical regions: Tuberculosis, enteric fever, malaria, visceral leishmaniasis 1

Medication History

  • Current treatments, especially immunosuppressants
  • Recent antibiotics that might mask infections
  • Over-the-counter medications

Social History

  • Living conditions and accommodation suitability
  • Smoking history 2
  • Occupational exposures
  • Animal contacts
  • Sexual history

Physical Examination Clues

Key Signs to Identify

  • Skin: Rashes, petechiae, eschar (suggests rickettsial disease)
  • Lymphadenopathy: Location, consistency, tenderness
  • Hepatosplenomegaly: Suggests infections (e.g., tuberculosis, brucellosis), lymphoma
  • Heart murmurs: Suggests endocarditis
  • Respiratory: Audible wheeze, tachypnea, use of accessory muscles 2
  • Neurological: Confusion, meningeal signs
  • Joint examination: Swelling, tenderness, range of motion

Special Considerations

  • Travelers: Look for signs of tropical infections 1
  • Immunocompromised patients: More thorough skin and mucosal examination
  • Elderly: Atypical presentations common, check for subtle signs

Laboratory Investigations

Initial Workup

  • Complete blood count with differential:
    • Lymphopenia: Viral infections (dengue, HIV), typhoid
    • Eosinophilia (>0.45×10⁹/L): Parasitic or fungal infections
    • Thrombocytopenia: Malaria, dengue, acute HIV, typhoid 2
  • Blood cultures: At least 2 sets (60 mL total) 1
  • Acute phase reactants: C-reactive protein, erythrocyte sedimentation rate 1
  • Liver function tests: Elevated alkaline phosphatase and LDH may suggest disseminated infections 2
  • Urinalysis: Proteinuria and hematuria in leptospirosis 2

Targeted Testing Based on Suspicion

  • Malaria films and dipstick antigen test (RDT): For all patients who visited tropical countries within 1 year; three thick films/RDTs over 72 hours to exclude malaria 2
  • Serum save for serology: HIV testing for patients with pneumonia, aseptic meningitis/encephalitis, diarrhea, viral hepatitis, lymphadenopathy 2
  • Stool examination: Wet preparation for amoebic trophozoites if bloody diarrhea 2
  • Ferritin levels: Levels >5000 ng/mL suggest adult-onset Still's disease 1
  • Glycosylated ferritin: Levels <20% highly specific for adult-onset Still's disease 1
  • Procalcitonin: Useful for diagnosing bacterial infections 1

Imaging Investigations

Initial Imaging

  • Chest radiograph: For all patients with PUO 1
  • Abdominal ultrasound: If abdominal symptoms or liver function abnormalities present 1

Advanced Imaging

  • 18F-FDG PET/CT: Consider early in the diagnostic process if initial workup is unrevealing; high diagnostic yield (56%) with sensitivity of 84-86% and specificity of 52-63% 1, 3
  • Whole body MRI: Useful to rule out oncologic disease and occult abscesses 2
  • CT paranasal sinuses: For neutropenic patients 2
  • CT chest/abdomen/pelvis with IV contrast: For neutropenic patients or if specific organ involvement suspected 2

Diagnostic Approach by Suspected Etiology

Infectious Causes

  • Tuberculosis: Extended blood cultures, tuberculin skin test, interferon-gamma release assay, biopsy of lymph nodes 1
  • Endocarditis: Multiple blood cultures, echocardiography 1
  • Abscesses: Targeted imaging based on symptoms 1
  • Brucellosis/Q fever: Serological testing 1

Inflammatory Causes

  • Adult-onset Still's disease: Ferritin, glycosylated ferritin 1
  • Vasculitis: ANCA, temporal artery biopsy in elderly 1
  • Connective tissue diseases: ANA, RF, anti-CCP antibodies 1

Neoplastic Causes

  • Lymphomas/leukemias: Peripheral blood smear, flow cytometry, bone marrow biopsy 1
  • Solid tumors: Targeted imaging based on symptoms 1

Special Scenarios

Returned Travelers

  • Malaria: Three thick films/RDTs over 72 hours 2
  • Dengue/viral hemorrhagic fevers: Risk assessment for VHF, serology 2
  • Enteric fever: Blood cultures (sensitivity up to 80% in typhoid) 2

Neutropenic Patients

  • Urgent evaluation: CT scans and bronchoscopy for pulmonary infiltrates 1
  • Central venous catheters: Evaluate catheter and peripheral blood cultures for differential time to positivity 1

HIV-Related PUO

  • Disseminated MAC: Look for severe anemia, elevated alkaline phosphatase, elevated LDH 2
  • Immune reconstitution syndrome: Consider in patients recently started on antiretroviral therapy 2

Common Pitfalls to Avoid

  • Initiating empiric antimicrobials without adequate investigation (except in neutropenic, immunocompromised, or critically ill patients) 4
  • Delaying 18F-FDG PET/CT until late in the diagnostic process 1
  • Starting glucocorticoid therapy without obtaining appropriate imaging 1
  • Neglecting to notify infectious diseases to local health protection units 2
  • Inadequate travel history documentation on laboratory request forms 2

By following this systematic approach, clinicians can efficiently work through the differential diagnosis of PUO and identify the underlying cause in most cases.

References

Guideline

Fever of Unknown Origin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

FDG PET/CT in evaluation of pyrexia of unknown origin.

Clinical nuclear medicine, 2011

Research

Fever of Unknown Origin in Adults.

American family physician, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.